home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

R&D Leaders' Forum Autumn 2007

  July 11, 2007  
Phacilitate Limited, The Vier Jahreszeiten Kempinski Hotel, Munich
15-17 October 2007

Visit www.phacilitate.co.uk/leaders for the latest programme information.
Organized by: Phacilitate Ltd
Invited Speakers: Visit www.phacilitate.co.uk/leaders for the full speaker list which includes: - Dr Norbert G. Riedel, Corporate Vice President, Chief Scientific Officer, Baxter International Inc - Dr Bernhard Kirschbaum, Senior Executive Vice President & Member of the Board, Head of Research, Merck Serono - Irene Norstedt, Deputy Head of Unit, Biotechnology, European Commission - Dr Emiliangelo Ratti, Senior Vice President & Head, Centre of Excellence for Drug Discovery in Psychiatry, GlaxoSmithKline - Dr Anthony Ford-Hutchinson, Executive Vice President, Research Medicine, Merck Research Laboratories, Merck & Co, Inc - Jo Walton, Managing Director & Research Analyst, Healthcare Research, Lehman Brothers - Joseph B. Bolen, PhD, Chief Scientific Officer, Millennium Pharmaceuticals, Inc - Kathryn M. Carbone, MD, Associate Director for Research, Center for Biologics Evaluation & Research, FDA - Dr Douglas Greene, Senior Vice President, Chief Medical Officer, Sanofi-Aventis - Professor Peter T. Sawicki, Director, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) - Dr Jörg Möller, Senior Vice President, Head, Global Clinical Development, Bayer HealthCare AG, Bayer Schering Pharma Division - Johan Van Hoof, MD, Senior Vice President & Global Head of Clinical Operations, Johnson & Johnson - Professor Klaus Nickisch, Senior Vice President, Global Project Management, Bayer Schering Pharma AG - Dr Paul C. Nakagaki, Head, Pharma Research Strategy, Pharmaceuticals Division, F. Hoffmann-La Roche Ltd - Dr William M. Kluwe, Global Head of Safety Assessment, Novartis Pharmaceuticals - Michael Leacock, Director, Pharmaceutical Equity Research, ABN AMRO - Dr Nicholas Dracopoli, Vice President, Clinical Discovery Technologies, Bristol-Myers Squibb Pharmaceutical Research Institute - Professor Andrew P. Grieve, Division of Health & Social Care Research, Department of Public Health Sciences, School of Medicine, King's College - Dr John J. Orloff, Vice President, Development, Novartis Pharmaceuticals Corporation - Dr Diana Galer, Vice President, Drug Safety Research & Development - Operations, Pfizer Inc - Dr Susanne Brendler-Schwaab, Head of Project Management Unit, Federal Institute for Drugs & Medical Devices - Professor Donald R. Stanski, Global Head, Modelling & Simulation, Novartis Pharma AG - Dr Damian O’Connell, Executive Director & Head of Experimental Medicine, Pfizer Global R&D - Dr Thomas Senderovitz, Vice President, Global Clinical Pharmacology & Experimental Medicine, UCB Pharma SA.
Deadline for Abstracts: n/a
Registration: Visit www.phacilitate.co.uk/leaders for information and online registration.
E-mail: nicola@phacilitate.co.uk
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.